The Chemours Company
CCBasic MaterialsNASDAQSpecialty Chemicals · Last scanned Oct 26, 2026
Scan Results
Daily timeframeHeadquartered within the basic materials sector, The Chemours Company focuses on Specialty Chemicals services and products. The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company carries a $1.93B market cap, placing it firmly in the small-cap category. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.
Market Cap
$1.93B
Beta
1.40
P/E (TTM)
—
P/E (Fwd)
6.89
EPS (TTM)
$-2.02
EPS (Fwd)
$1.86
ROE
-319.4%
ROA
1.4%
Cash
$671.0M
Total Debt
$4.12B
Free CF
$303.1M
52W Change
-8.5%
Annual Financials
Cash vs Debt
Where CC stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, CC finished 33.09% below its 150-day moving average ($18.86) and 31.00% below its 200-day moving average ($18.29). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CC overbought or oversold?
At the October 20, 2026 close, CC's RSI(14) was 25.5, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $671.0M in cash, though total debt stands at $4.12B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $303.1M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at -319.4%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 1.4% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $6.34B (2021) to $5.81B (2025).
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for The Chemours Company and its sector.